In keeping with this, the 0822 GBM stem cell line treated with anti-miR-582-5p expressed higher Caspase 3 and Caspase 9 as compared to anti-miR scrambled control (Figure 4B, S3B in File S1, and S6 in File S2). Here, CASP9 is linked to glioblastoma.